New Leaf Venture Partners

Portfolio Co Investors 2026 for New Leaf Venture Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

New Leaf Venture Partners accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $2B. The median disclosed raise is $69M, and the largest is Edgewise Therapeutics at $495M, ahead of TigerConnect ($426M) and UNUM Therapeutics ($181M).

The names that recur most often on these co-invested cap tables are New Leaf Venture Partners (15 companies), Novo Holdings (2 companies), Longitude Capital (2 companies), OrbiMed (1 company), RA Capital (1 company), Viking Global (1 company). By latest disclosed round, the market skews Series B (6), Series C (4), Growth (2), Series E (2).

Best funded New Leaf Venture Partners companies

  1. Edgewise Therapeutics — $495M (latest: Growth)
  2. TigerConnect — $426M (latest: Series E)
  3. UNUM Therapeutics — $181M (latest: Series B)
  4. BrightInsight — $166M (latest: Series C)
  5. ReViral — $154M (latest: IPO)
  6. Aptinyx — $135M (latest: Series B)
  7. Truveris — $69M (latest: Series E)
  8. Glympse Bio — $69M (latest: Series B)
  9. Saniona — $65M (latest: Growth)
  10. CuraSen Therapeutics — $60M (latest: Series B)
  11. AiCure — $56M (latest: Series C)
  12. Qlaris Bio — $49M (latest: Series B)
  13. Harpoon Therapeutics — $45M (latest: Series B)
  14. Flosonics — $39M (latest: Series C)
  15. Leaf Biotech — $28M (latest: Series C)

New Leaf Venture Partners — related firms and companies (56)

New Leaf Venture Partners alternatives · All research reports